Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The Genetic Landscape of Diamond-Blackfan Anemia.

Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O'Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O'Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT.

Am J Hum Genet. 2019 Feb 7;104(2):356. doi: 10.1016/j.ajhg.2018.12.011. No abstract available.

2.

Mammalian Hbs1L deficiency causes congenital anomalies and developmental delay associated with Pelota depletion and 80S monosome accumulation.

O'Connell AE, Gerashchenko MV, O'Donohue MF, Rosen SM, Huntzinger E, Gleeson D, Galli A, Ryder E, Cao S, Murphy Q, Kazerounian S, Morton SU, Schmitz-Abe K, Gladyshev VN, Gleizes PE, Séraphin B, Agrawal PB.

PLoS Genet. 2019 Feb 1;15(2):e1007917. doi: 10.1371/journal.pgen.1007917. eCollection 2019 Feb.

3.

The Genetic Landscape of Diamond-Blackfan Anemia.

Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O'Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O'Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT.

Am J Hum Genet. 2018 Dec 6;103(6):930-947. doi: 10.1016/j.ajhg.2018.10.027. Epub 2018 Nov 29. Erratum in: Am J Hum Genet. 2019 Feb 7;104(2):356.

4.

["Blue eyes"-case report about the risks of cosmetic iris implants].

Kazerounian S, Tsirkinidou I, Kynigopoulos M, Müller M.

Ophthalmologe. 2019 Jul;116(7):669-672. doi: 10.1007/s00347-018-0792-z. German.

PMID:
30306299
5.

Integration of pro- and anti-angiogenic signals by endothelial cells.

Kazerounian S, Lawler J.

J Cell Commun Signal. 2018 Mar;12(1):171-179. doi: 10.1007/s12079-017-0433-3. Epub 2017 Dec 20. Review.

6.

Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.

Paul C, Heun C, Müller HH, Hoerauf H, Feltgen N, Wachtlin J, Kaymak H, Mennel S, Koss MJ, Fauser S, Maier MM, Schumann RG, Mueller S, Chang P, Schmitz-Valckenberg S, Kazerounian S, Szurman P, Lommatzsch A, Bertelmann T.

Br J Ophthalmol. 2018 Aug;102(8):1092-1097. doi: 10.1136/bjophthalmol-2017-310874. Epub 2017 Oct 31.

PMID:
29089354
7.

The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study.

Bertelmann T, Wachtlin J, Mennel S, Koss MJ, Maier MM, Schumann RG, Kazerounian S, Daniel H, Schmitz-Valckenberg S; EXPORT study group.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1359-1367. doi: 10.1007/s00417-017-3657-2. Epub 2017 Apr 7.

PMID:
28389700
8.

Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation.

Kim AR, Ulirsch JC, Wilmes S, Unal E, Moraga I, Karakukcu M, Yuan D, Kazerounian S, Abdulhay NJ, King DS, Gupta N, Gabriel SB, Lander ES, Patiroglu T, Ozcan A, Ozdemir MA, Garcia KC, Piehler J, Gazda HT, Klein DE, Sankaran VG.

Cell. 2017 Mar 9;168(6):1053-1064.e15. doi: 10.1016/j.cell.2017.02.026.

9.

Digital Pupillometry in Normal Subjects.

Rickmann A, Waizel M, Kazerounian S, Szurman P, Wilhelm H, Boden KT.

Neuroophthalmology. 2016 Oct 3;41(1):12-18. doi: 10.1080/01658107.2016.1226345. eCollection 2017 Feb.

10.

VITRECTOMY FOR PERSISTENT MACULAR HOLES FOLLOWING OCRIPLASMIN INJECTION: A Comparative Multicenter Study.

Schumann RG, Wolf A, Hoerauf H, Lommatzsch A, Maier M, Wachtlin J, Koss MJ, Kreutzer T, Bertelmann T, Kazerounian S, Mennel S, Priglinger SG.

Retina. 2017 Dec;37(12):2295-2303. doi: 10.1097/IAE.0000000000001473.

PMID:
28098729
11.

IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPY.

Paul C, Heun C, Müller HH, Fauser S, Kaymak H, Kazerounian S, Sekundo W, Mennel S, Meyer CH, Schmitz-Valckenberg S, Koss MJ, Feltgen N, Bertelmann T.

Retina. 2017 Jul;37(7):1252-1260. doi: 10.1097/IAE.0000000000001371.

PMID:
27787446
12.

A novel pathogenic mutation in RPL11 identified in a patient diagnosed with diamond Blackfan anemia as a young adult.

Narla A, Yuan D, Kazerounian S, LaVasseur C, Ulirsch JC, Narla J, Glader B, Sankaran VG, Gazda H.

Blood Cells Mol Dis. 2016 Oct;61:46-7. doi: 10.1016/j.bcmd.2016.08.001. Epub 2016 Aug 17. No abstract available.

PMID:
27667165
13.

Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Hemorrhages.

Waizel M, Todorova MG, Kazerounian S, Rickmann A, Blanke BR, Szurman P.

Ophthalmologica. 2016;236(3):123-132. Epub 2016 Sep 16.

PMID:
27631507
14.

Phoneme restoration and empirical coverage of Interactive Activation and Adaptive Resonance models of human speech processing.

Grossberg S, Kazerounian S.

J Acoust Soc Am. 2016 Aug;140(2):1130. doi: 10.1121/1.4946760.

PMID:
27586743
15.

Author's reply to comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD.

Waizel M, Kazerounian S, Rickmann A, Wolf K, Blanke BR, Todorova MG.

Eur J Ophthalmol. 2016 Aug 4;26(5):e139-40. doi: 10.5301/ejo.5000842. No abstract available.

PMID:
27405283
16.

Mutations in the substrate binding glycine-rich loop of the mitochondrial processing peptidase-α protein (PMPCA) cause a severe mitochondrial disease.

Joshi M, Anselm I, Shi J, Bale TA, Towne M, Schmitz-Abe K, Crowley L, Giani FC, Kazerounian S, Markianos K, Lidov HG, Folkerth R, Sankaran VG, Agrawal PB.

Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000786. doi: 10.1101/mcs.a000786.

17.

Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD.

Waizel M, Rickmann A, Blanke BR, Wolf K, Kazerounian S, Szurman P.

Eur J Ophthalmol. 2016 Aug 4;26(5):469-72. doi: 10.5301/ejo.5000781. Epub 2016 Apr 12.

PMID:
27079204
18.

[Management of Radius-Maumenee syndrome : Treatment with deep sclerectomy, viscocanalostomy and collagen matrix implantation].

Kazerounian S, Rickmann A, Helaiwa K, Waizel M.

Ophthalmologe. 2016 Sep;113(9):775-8. doi: 10.1007/s00347-015-0213-5. German.

PMID:
26782914
19.

Development of Soft Tissue Sarcomas in Ribosomal Proteins L5 and S24 Heterozygous Mice.

Kazerounian S, Ciarlini PD, Yuan D, Ghazvinian R, Alberich-Jorda M, Joshi M, Zhang H, Beggs AH, Gazda HT.

J Cancer. 2016 Jan 1;7(1):32-6. doi: 10.7150/jca.13292. eCollection 2016.

20.

Thrombospondin-1 Modulates Actin Filament Remodeling and Cell Motility in Mouse Mammary Tumor cells in Vitro.

Ndishabandi D, Duquette C, Billah GE, Reyes M, Duquette M, Lawler J, Kazerounian S.

Discoveries (Craiova). 2014 Oct-Dec;2(4). pii: e31.

21.

[Upper eyelid swelling].

Kazerounian S, Szurman P, Waizel M.

Ophthalmologe. 2015 Aug;112(8):691-3. doi: 10.1007/s00347-015-0071-1. German. No abstract available.

PMID:
26002379
22.

[Shock-induced anterior ischemic optic neuropathy from hemorrhagic anemia].

Kazerounian S, Sekundo W, Droutsas K.

Ophthalmologe. 2015 Apr;112(4):368-72. doi: 10.1007/s00347-014-3139-4. German.

PMID:
25619165
23.

Real-time learning of predictive recognition categories that chunk sequences of items stored in working memory.

Kazerounian S, Grossberg S.

Front Psychol. 2014 Oct 6;5:1053. doi: 10.3389/fpsyg.2014.01053. eCollection 2014.

24.

RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription.

Gerald D, Adini I, Shechter S, Perruzzi C, Varnau J, Hopkins B, Kazerounian S, Kurschat P, Blachon S, Khedkar S, Bagchi M, Sherris D, Prendergast GC, Klagsbrun M, Stuhlmann H, Rigby AC, Nagy JA, Benjamin LE.

Nat Commun. 2013;4:2824. doi: 10.1038/ncomms3824.

25.

An intrinsic value system for developing multiple invariant representations with incremental slowness learning.

Luciw M, Kompella V, Kazerounian S, Schmidhuber J.

Front Neurorobot. 2013 May 30;7:9. doi: 10.3389/fnbot.2013.00009. eCollection 2013.

26.

RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis.

Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L, Pourat J, Phung TL, Bravo-Nuevo A, Shechter S, McNamara S, Duhadaway JB, Kocher ON, Brown LF, Toker A, Prendergast GC, Benjamin LE.

Cancer Res. 2013 Jan 1;73(1):50-61. doi: 10.1158/0008-5472.CAN-11-3055. Epub 2012 Nov 7.

27.

Laminar cortical dynamics of conscious speech perception: neural model of phonemic restoration using subsequent context in noise.

Grossberg S, Kazerounian S.

J Acoust Soc Am. 2011 Jul;130(1):440-60. doi: 10.1121/1.3589258.

PMID:
21786911
28.

Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Kazerounian S, Duquette M, Reyes MA, Lawler JT, Song K, Perruzzi C, Primo L, Khosravi-Far R, Bussolino F, Rabinovitz I, Lawler J.

Blood. 2011 Apr 28;117(17):4658-66. doi: 10.1182/blood-2010-09-305284. Epub 2011 Mar 4.

29.

RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice.

Bravo-Nuevo A, Sugimoto H, Iyer S, Fallon Z, Lucas JM, Kazerounian S, Prendergast GC, Kalluri R, Shapiro NI, Benjamin LE.

Am J Pathol. 2011 Jan;178(1):245-52. doi: 10.1016/j.ajpath.2010.11.040. Epub 2010 Dec 23.

30.

Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.

Zhang X, Kazerounian S, Duquette M, Perruzzi C, Nagy JA, Dvorak HF, Parangi S, Lawler J.

FASEB J. 2009 Oct;23(10):3368-76. doi: 10.1096/fj.09-131649. Epub 2009 Jun 15.

31.

The effect of thrombospondin-1 on breast cancer metastasis.

Yee KO, Connolly CM, Duquette M, Kazerounian S, Washington R, Lawler J.

Breast Cancer Res Treat. 2009 Mar;114(1):85-96. doi: 10.1007/s10549-008-9992-6. Epub 2008 Apr 13.

32.

Thrombospondins in cancer.

Kazerounian S, Yee KO, Lawler J.

Cell Mol Life Sci. 2008 Mar;65(5):700-12. doi: 10.1007/s00018-007-7486-z. Review.

33.
34.

Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins.

Kazerounian S, Pitari GM, Shah FJ, Frick GS, Madesh M, Ruiz-Stewart I, Schulz S, Hajnóczky G, Waldman SA.

J Pharmacol Exp Ther. 2005 Sep;314(3):1013-22. Epub 2005 Jun 3.

PMID:
15937149
35.

Reciprocal regulation and integration of signaling by intracellular calcium and cyclic GMP.

Tiyyagura SR, Kazerounian S, Schulz S, Waldman SA, Pitari GM.

Vitam Horm. 2004;69:69-94. Review.

PMID:
15196879
36.

Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism.

Ruiz-Stewart I, Tiyyagura SR, Lin JE, Kazerounian S, Pitari GM, Schulz S, Martin E, Murad F, Waldman SA.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):37-42. Epub 2003 Dec 18.

37.
38.

Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter.

Rathi S, Kazerounian S, Banwait K, Schulz S, Waldman SA, Rattan S.

J Pharmacol Exp Ther. 2003 May;305(2):615-24. Epub 2003 Feb 11.

PMID:
12606629
39.

Bacterial enterotoxins are associated with resistance to colon cancer.

Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, Hajnóczky G, Terzic A, Waldman SA.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2695-9. Epub 2003 Feb 19.

40.
41.

Paraneoplastic pemphigus in children and adolescents.

Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, Mascaro JM Jr, Nousari HC.

Br J Dermatol. 2002 Oct;147(4):725-32.

PMID:
12366419
42.

Soluble guanylate cyclase is allosterically inhibited by direct interaction with 2-substituted adenine nucleotides.

Ruiz-Stewart I, Kazerounian S, Pitari GM, Schulz S, Waldman SA.

Eur J Biochem. 2002 Apr;269(8):2186-93.

43.

Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium.

Kazerounian S, Pitari GM, Ruiz-Stewart I, Schulz S, Waldman SA.

Biochemistry. 2002 Mar 12;41(10):3396-404.

PMID:
11876648
44.

Guanylyl cyclases and signaling by cyclic GMP.

Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA.

Pharmacol Rev. 2000 Sep;52(3):375-414. Review.

PMID:
10977868
45.

Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies.

Kazerounian S, Mahoney MG, Uitto J, Aho S.

J Invest Dermatol. 2000 Sep;115(3):505-7. No abstract available.

46.

Generic and alternative brand-name pharmaceutical equivalents: select with caution.

Hendeles L, Hochhaus G, Kazerounian S.

Am J Hosp Pharm. 1993 Feb;50(2):323-9. Review. No abstract available. Erratum in: Am J Hosp Pharm 1993 May;50(5):913.

PMID:
8480793

Supplemental Content

Loading ...
Support Center